Literature DB >> 7026195

Dexamethasone hypertension in rats.

T Okuno, H Suzuki, T Saruta.   

Abstract

The effects of dexamethasone (DEX) on systolic blood pressure, sodium balance and the renin-angiotensin system were studied in rats. DEX significantly increased systolic blood pressure within three days of its administration, but this effect of DEX on blood pressure was not enhanced by concurrent use of saline solution. In DEX-treated rats, urine volume was significantly increased and urinary sodium excretion showed a tendency toward a slight increase compared to control rats. On the 8th day of DEX administration, plasma renin substrate (PRS) was significantly elevated compared to control rats, whereas plasma aldosterone concentration (PAC) was not significantly different from that of control rats. These results suggest that hypertension induced by DEX may not be dependent on sodium retention or activation of the renin-angiotensin system.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7026195     DOI: 10.3109/10641968109033722

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 0148-3927            Impact factor:   1.749


  3 in total

1.  Age-related changes in thirst, salt appetite, and arterial blood pressure in response to aldosterone-dexamethasone combination in rats.

Authors:  Robert L Thunhorst; Baojian Xue; Terry G Beltz; Alan Kim Johnson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-04-01       Impact factor: 3.619

Review 2.  Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data.

Authors:  J A P Da Silva; J W G Jacobs; J R Kirwan; M Boers; K G Saag; L B S Inês; E J P de Koning; F Buttgereit; M Cutolo; H Capell; R Rau; J W J Bijlsma
Journal:  Ann Rheum Dis       Date:  2005-08-17       Impact factor: 19.103

3.  Glucocorticoids increase salt appetite by promoting water and sodium excretion.

Authors:  Robert L Thunhorst; Terry G Beltz; Alan Kim Johnson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2007-06-27       Impact factor: 3.619

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.